OMX Nordic 40
|
2 454,71
|
-10,05
|
-0,41 %
|
Analysen zu OMX Nordic 40-Werten
| 19.11.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 19.11.25 | ABB Underperform | Bernstein Research | |
| 18.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 18.11.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 18.11.25 | Novo Nordisk Neutral | UBS AG | |
| 18.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 17.11.25 | ABB Sector Perform | RBC Capital Markets | |
| 14.11.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 12.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 11.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Novo Nordisk Halten | DZ BANK | |
| 10.11.25 | AstraZeneca Halten | DZ BANK | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | AstraZeneca Outperform | Bernstein Research | |
| 10.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.11.25 | Nokia Buy | Deutsche Bank AG | |
| 10.11.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 10.11.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 07.11.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 07.11.25 | AstraZeneca Sell | Deutsche Bank AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 07.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 07.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 06.11.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 06.11.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 05.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.11.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.11.25 | Novo Nordisk Outperform | Bernstein Research | |
| 04.11.25 | Nokia Buy | Jefferies & Company Inc. | |
| 31.10.25 | AstraZeneca Buy | UBS AG | |
| 31.10.25 | Novo Nordisk Buy | Deutsche Bank AG |
HOT STOCKS DER LETZTEN 3 TAGE
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.